Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

SEVELAMER HCL 800 MG TABLET

Sevelamer hydrochloride
$0.7910per EA

Strength

800 mg/1

Manufacturer

Lupin Pharmaceuticals Inc.

NDC

70748017326

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

SEVELAMER HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA213145

On Market Since

2/25/2022

Pharmacological Classes

Phosphate Binder
Phosphate Chelating Activity

Price History

1W

0.0%

1M

-7.6%

3M

-24.5%

6M

-41.3%

1Y

-28.5%

3Y

-63.9%

5Y

N/A

All

-82.5%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

LACTATED RINGERS INJECTION
Generic
00338011704•Baxter Healthcare Corporation
$0.0020
per ML
LACTATED RINGERS INJECTION
Generic
00264775000•B. Braun Medical Inc.
$0.0040
per ML
LACTATED RINGERS INJECTION
Generic
00264775007•B. Braun Medical Inc.
$0.0040
per ML
LACTATED RINGERS INJECTION
Generic
00264775010•B. Braun Medical Inc.
$0.0040
per ML
LACTATED RINGERS INJECTION
Generic
00338011703•Baxter Healthcare Corporation
$0.0040
per ML
LACTATED RINGERS 1,000 ML
Generic
00338960012•Baxter Healthcare Corporation
$0.0040
per ML
LACTATED RINGERS INJECTION
Generic
00990795303•ICU Medical Inc.
$0.0040
per ML
LACTATED RINGERS INJECTION
Generic
00990795309•ICU Medical Inc.
$0.0040
per ML
CALCIUM CARB 500 MG TAB CHEW
Generic
69618002015•Reliable 1 Laboratories LLC
$0.0129
per EA
QC ANTACID 500 MG CHEW TABLET
Generic
63868004715•Chain Drug Marketing Association
$0.0134
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy